Mackenzie Financial’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-52,960
Closed -$396K 1762
2025
Q4
$396K Sell
52,960
-16,521
-24% -$113K ﹤0.01% 1287
2025
Q3
$472K Buy
+69,481
New +$470K ﹤0.01% 1262
2025
Q2
Sell
-57,727
Closed -$420K 1806
2025
Q1
$420K Sell
57,727
-6,706
-10% -$52.7K ﹤0.01% 1253
2024
Q4
$517K Buy
64,433
+44,636
+225% +$387K ﹤0.01% 1163
2024
Q3
$145K Buy
+19,797
New +$141K ﹤0.01% 1439
2023
Q4
Sell
-13,275
Closed -$89.2K 1586
2023
Q3
$89.2K Buy
+13,275
New +$109K ﹤0.01% 1360
2022
Q3
Sell
-10,172
Closed -$55K 1518
2022
Q2
$55K Buy
+10,172
New +$54.8K ﹤0.01% 1388
2020
Q3
Sell
-10,827
Closed -$103K 1059
2020
Q2
$103K Buy
+10,827
New +$84.2K ﹤0.01% 970

Other funds holding VMD

Mackenzie Financial's VMD Position: Q1 2026 in Review

Mackenzie Financial sold out of Viemed Healthcare (VMD) in Q1 2026, closing a stake of 52,960 shares — an estimated $396K sold.

Mackenzie Financial first reported a position in VMD in Q2 2020 and held it in 8 quarters. The position peaked at $517K in Q4 2024. 150 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

  • Mackenzie Financial reported no remaining Viemed Healthcare position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 52,960 Viemed Healthcare shares in Q1 2026, an estimated $396K.
  • Mackenzie Financial first reported a position in Viemed Healthcare in Q2 2020 and held it in 8 quarters.
  • Mackenzie Financial's Viemed Healthcare position peaked at $517K in Q4 2024.
  • 150 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.